Wolverine Trading
LABD icon

Wolverine Trading’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Wolverine Trading’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,225
Closed -$199K – 4810
2023
Q2 		$180K Buy
+1,225
New +$183K ﹤0.01% 3572
2023
Q1 		– Sell
-2,162
Closed -$367K – 4611
2022
Q4 		$373K Buy
2,162
+418
+24% +$85.7K ﹤0.01% 2583
2022
Q3 		$425K Buy
+1,744
New +$405K ﹤0.01% 2793
2021
Q4 		– Sell
-3,416
Closed -$786K – 6397
2021
Q3 		$731K Buy
3,416
+1,526
+81% +$325K ﹤0.01% 3417
2021
Q2 		$362K Buy
+1,890
New +$424K ﹤0.01% 4149
2020
Q4 		– Sell
-894
Closed -$341K – 5165
2020
Q3 		$527K Buy
894
+476
+114% +$307K ﹤0.01% 2757
2020
Q2 		$302K Buy
418
+88
+27% +$111K ﹤0.01% 3334
2020
Q1 		$910K Buy
330
+216
+189% +$616K ﹤0.01% 2021
2019
Q4 		$286K Buy
+114
New +$405K ﹤0.01% 3647

Other funds holding LABD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Wolverine Trading's LABD Position: Q3 2023 in Review

Wolverine Trading sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2023, closing a stake of 1,225 shares — an estimated $199K sold.

Wolverine Trading first reported a position in LABD in Q4 2019 and held it in 9 quarters. The position peaked at $910K in Q1 2020. 16 funds tracked by Wall St. Rank hold LABD as of Q3 2023.

  • Wolverine Trading reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q3 2023 after selling out during the quarter.
  • Wolverine Trading sold 1,225 Direxion Daily S&P Biotech Bear 3X ETF shares in Q3 2023, an estimated $199K.
  • Wolverine Trading first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2019 and held it in 9 quarters.
  • Wolverine Trading's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $910K in Q1 2020.
  • 16 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2023.

Based on Wolverine Trading's 13F filing for Q3 2023, filed 15 Nov 2023.